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At present there are two methods to determine the
chromosome health of unborn fetus in pregnant
women. One is through maternal serum screening that
is considered as simple but less sensitive method and
the second options involves invasive methods like
amniocentesis or chorionic villus sampling (CVS) for
women who are found to be positive in maternal serum
screening. Recent studies have demonstrated that non-
invasive prenatal testing (NIPT) using cell-free fetal
DNA (cfDNA) present in circulating maternal blood is
considered as one the most effective method of screen-
ing for trisomy 21.
The single nucleotide polymorphism (SNP) based
Non-invasive Pre-natal test, being offered by Quest
Diagnostics in technical collaboration with Natera Inc to
determine chromosomal copy number by looking for
specific patterns of (SNPs). This second generation tech-
nology analyzes cfDNA in a single reaction targeting
19,500 single nucleotide polymorphisms which are the
most informative portions of an individual’s DNA
selected across all the analyzed chromosomes.
Two published study demonstrated in the women
undergone both invasive chorionic villus samplings fol-
lowed by karyotyping in conjunction with non-invasive
prenatal testing the efficacy of test. Data from Nicolaides
et al., 2013 paper on total of 242 cases that include
thirty two cases aneuploidy included trisomy 21 (n=25)
which were correctly identified with 100% sensitivity
and 100% specificity with no false positive and false
negative. Another study by Zimmerman et al., 2012
study on 166 samples from pregnant women, including
11 trisomy 21, three trisomy 18, two trisomy 13, two 45,
X, and two 47,XXY samples including 146 low risk
pregnancies. The study also correctly reported the chro-
mosome copy number of all five chromosomes in 145
samples that passed a DNA quality test.
The studies had demonstrated that SNP based NIPT is
considered as an effective method of screening for com-
mon chromosomal abnormalities with detection rate of
more than 99% and false positive rate of less than 0.1%.
The initial finding shows NIPT approach has potential to
avoid invasive procedure and can be provided an option to
high risk pregnancies i.e. those with advanced maternal
age, screens positive for biochemical screening and history
of pregnancies with previous aneuploidies.
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